GENESYS REGIONAL MEDICAL CTR. — History
CCN 230197 | 3-year financial timeline | COVID resilience: 22/100
🛡️ Public data only — no PHI permitted on this instance.
$363M
Latest Revenue (FY2022)
-5.8%
Revenue CAGR (3yr)
-10.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $409M | $401M | $363M | -9.4% | -5.8% |
| Operating Expenses | $407M | $439M | $400M | -8.8% | -0.8% |
| Operating Margin | 0.6% | -9.5% | -10.2% | -7.2% | +0.0% |
| Net Income | $3M | $-38M | $-37M | +2.9% | +0.0% |
| Licensed Beds | 350 | 353 | 333 | -5.7% | -2.5% |
| Total Patient Days | 79,066 | 89,306 | 82,635 | -7.5% | +2.2% |
| Medicare Day % | 30% | 26% | 25% | -3.6% | -8.2% |
| Medicaid Day % | 4% | 3% | 3% | -1.4% | -7.5% |
COVID Impact & Recovery
Resilience Score: 22/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -11.2% ($409M → $363M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-5.8%
This Hospital
+7.6%
State Avg
Latest Margin
-10.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $341M | -15.6% |
| FY2024 (proj) | $318M | -20.9% |
| FY2025 (proj) | $295M | -26.3% |